| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
959 |
851 |
$69K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
565 |
527 |
$44K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
869 |
761 |
$41K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
523 |
484 |
$25K |
| 99000 |
|
767 |
698 |
$16K |
| 87428 |
|
154 |
147 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
242 |
210 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
479 |
421 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
145 |
120 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
232 |
189 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
155 |
143 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
54 |
46 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
47 |
35 |
$2K |
| 81002 |
|
256 |
230 |
$658.93 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
48 |
37 |
$523.90 |
| 81025 |
|
61 |
59 |
$343.75 |